23— INCOME TAXES

23-1     Income / (Loss) before income taxes

Income / (loss) before income taxes is comprised of the following:

Year Ended December 31, 

  ​ ​ ​

2025

  ​ ​ ​

2024

France

(15,513)

(5,630)

Other countries

 

(13,295)

 

(14,641)

Total

 

(28,808)

 

(20,271)

23-2     Income tax (expense)/ benefit

Income tax (expense)/benefit consists of the following:

Year Ended December 31, 

  ​ ​ ​

2025

  ​ ​ ​

2024

Current income tax expense:

  ​

  ​

France

 

(45)

 

(50)

Other countries

 

(558)

 

(384)

Sub-total current income tax expense

 

(603)

 

(434)

Deferred income tax (expense) benefit:

 

  ​

 

  ​

France

 

2

 

5

Other countries

 

163

 

116

Sub-total deferred income tax (expense) benefit

 

165

 

121

Total

 

(438)

 

(313)

23-3     Deferred income taxes:

Deferred income taxes reflect the impact of temporary differences between the amounts of assets and liabilities reported for financial reporting purposes and such amounts as measured in accordance with tax laws. The tax effects of temporary differences which give rise to significant deferred tax assets (liabilities) are as follows by nature:

  ​ ​ ​

2025

  ​ ​ ​

2024

Net operating loss carry forwards

29,392

21,551

Elimination of intercompany profit in inventory

 

351

 

469

Elimination of intercompany profit in fixed assets

 

596

 

428

Provisions for retirement indemnities

 

780

 

716

Capital leases treated as operating leases for tax

 

9

 

8

Other items

 

552

 

369

Total deferred tax assets

 

31,679

 

23,542

Total deferred tax liabilities

 

 

Net deferred tax assets

 

31,679

 

23,542

Valuation allowance for deferred tax assets

 

(30,585)

 

(22,677)

Deferred tax assets (liabilities), net of allowance

 

1,094

 

865

Net operating loss carryforwards available amount to $129,037 thousand as of December 31, 2025, of which $54,135 thousand relates to EDAP TMS SA, $73,160 thousand relates to Edap Technomed Inc., $735 thousand relates to Edap TMS Gmbh and $1,007 thousand relates to Edap Technomed Co Ltd Japan. These net operating losses generate deferred tax assets of $29,392 thousand as at December 31, 2025. Realization of these tax assets is contingent on future taxable earnings in the applicable tax jurisdictions. As of December 31, 2025, $128,030 thousand out of these $129,037 thousand net operating loss carry-forwards have no expiration date but the amount of the net operating loss carry-forward, which can be used each year to offset taxable earnings, is limited in all jurisdictions. The remaining tax loss carry-forwards expire in 2025. In accordance with ASC 740, a valuation allowance is established if, based on the weight of available evidence, it is more-likely-than-not that some portion or all of the deferred tax asset will not be realized.

23-4     Effective tax income (expense)

A reconciliation of differences between the statutory French income tax rate and the Company’s effective tax income (loss) is as follows:

  ​ ​ ​

2025

  ​ ​ ​

2024

Theoretical income tax (expense) benefit at French statutory tax rate

7,202

25.0%

5,068

25.0%

Income of foreign subsidiaries taxed at different tax rates

 

(589)

(2.0)%

 

(591)

(2.9)%

Effect of net operating loss carry-forwards and valuation allowances

 

(6,185)

(21.5)%

 

(4,796)

(23.7)%

Non-taxable debt fair value variation

 

(622)

(2.2)%

 

0.0%

Permanent differences

 

(184)

(0.6)%

 

(305)

(1.5)%

Effect of cancellation of intra-group positions

 

(1)

0.0%

 

289

1.4%

French business tax included in income tax (CVAE)

 

(34)

(0.1)%

 

(44)

(0.2)%

Other

 

(25)

(0.1)%

 

67

0.3%

Effective income tax (expense) benefit

 

(438)

(1.5)%

 

(313)

(1.5)%

The valuation allowances for deferred taxes presented on the line "Effect of net operating loss carry-forwards and valuation allowances" include some additional categories compared to note 23-3 and include mainly R&D tax credit, stock options and foreign exchange rates.

23-5     Uncertainty in Income Taxes

According to ASC 740, the Company reviewed the tax positions of each subsidiary. On December 31, 2025 the Company believes that there is no significant uncertainty in the Company’s tax positions.

The Company remains subject to examination by major tax jurisdictions.

Interest and penalties on income taxes are classified as a component of the provision for income taxes. There were no interest or penalties in 2025 and 2024.

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.